The 20 Best Heterozygous Familial Hypercholesterolemia (HeFH) Doctors Near Me

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, High Cholesterol, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery. Dr. Blumenthal is board certified in American Board Of Internal Medicine.

Christie Ballantyne is a Cardiologist practicing medicine in Houston, Texas. He has been practicing medicine for over 44 years. Dr. Ballantyne is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Familial Hypertriglyceridemia, High Cholesterol, Atherosclerosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Hayato Tada practices practicing medicine in Kanazawa, Japan. Mr. Tada is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Familial Hypercholesterolemia, High Cholesterol, Sitosterolemia, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Daniel Gaudet practices practicing medicine in Chicoutimi, Canada. Mr. Gaudet is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypertriglyceridemia, Familial Lipoprotein Lipase Deficiency, and Apolipoprotein C2 Deficiency.

Robert Hegele practices practicing medicine in London, Canada. Hegele is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). They are also highly rated in 35 other conditions, according to our data. Their clinical expertise encompasses Familial Hypertriglyceridemia, High Cholesterol, Apolipoprotein C2 Deficiency, and Familial Lipoprotein Lipase Deficiency.

Raul Santos practices practicing medicine in Sao Paulo, Brazil. Mr. Santos is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), and Angioplasty.

Gerald Watts practices practicing medicine in Nedlands, Australia. Mr. Watts is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Familial Hypertriglyceridemia, Defective Apolipoprotein B-100, and Liver Transplant.

Shizuya Yamashita practices practicing medicine in Suita, Japan. Yamashita is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). They are also highly rated in 16 other conditions, according to our data. Their clinical expertise encompasses Familial Hypertriglyceridemia, High Cholesterol, Protein Deficiency, Liver Transplant, and Cardiac Ablation.

Maciej Banach practices practicing medicine in Plock, Poland. Mr. Banach is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Atherosclerosis, Hypertension, Kidney Transplant, and Percutaneous Coronary Intervention (PCI).

Wei Li practices practicing medicine in Nanjing, China. Li is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). They are also highly rated in 580 other conditions, according to our data. Their clinical expertise encompasses Lung Adenocarcinoma, Type 2 Diabetes (T2D), Lung Cancer, Endoscopy, and Thrombectomy.

Salim Virani is a primary care provider, practicing in Cardiologist in Houston, Texas. Dr. Virani is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Coronary Heart Disease, High Cholesterol, Coronary Artery Bypass Graft (CABG), and Percutaneous Coronary Intervention (PCI).

Mariko Shiba-Harada practices practicing medicine in Osaka, Japan. Ms. Shiba-Harada is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Heterozygous Familial Hypercholesterolemia (HeFH), High Cholesterol, Familial Hypercholesterolemia, and Homozygous Familial Hypercholesterolemia (HoFH).

Frederick Raal practices practicing medicine in Johannesburg, South Africa. Mr. Raal is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Homozygous Familial Hypercholesterolemia (HoFH), Heterozygous Familial Hypercholesterolemia (HeFH), High Cholesterol, and Familial Hypercholesterolemia.

Eric Bruckert practices practicing medicine in Paris, France. Mr. Bruckert is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Erik Stroes practices practicing medicine in Amsterdam, Netherlands. Mr. Stroes is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Atherosclerosis, and Carotid Artery Surgery.

John Kastelein practices practicing medicine in Amsterdam, Netherlands. Mr. Kastelein is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), and Heterozygous Familial Hypercholesterolemia (HeFH).

Claudio Borghi practices practicing medicine in Bologna, Italy. Mr. Borghi is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Hypertension, High Cholesterol, Gout, Metabolic Syndrome, and Hormone Replacement Therapy (HRT).

Handrean Soran practices practicing medicine in Manchester, United Kingdom. Soran is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). They are also highly rated in 19 other conditions, according to our data. Their clinical expertise encompasses Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, High Cholesterol, Gastric Bypass, and Gastrectomy.

Dirk Blom practices practicing medicine in Cape Town, South Africa. Mr. Blom is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Homozygous Familial Hypercholesterolemia (HoFH), Familial Hypercholesterolemia, High Cholesterol, Heterozygous Familial Hypercholesterolemia (HeFH), and Hormone Replacement Therapy (HRT).